Arkema stock came into this earnings print looking beaten up, with a 90 day return that declined 5%, yet trading on just 0.5x sales and a dividend yield above 6%. That sets up a sharp expectation gap, as the market priced in margin fatigue and weak profitability. The quarter instead put profitability back at center stage.
The headline this time is earnings before interest, tax, depreciation and amortization. Arkema delivered €391m of EBITDA with a 16.1% margin and about 90 basis points of margin recovery. Management also held the line on guidance for slight EBITDA growth in 2026. The stock now has to reconcile that margin story with its lowly valuation.
Love Arkema's margin resilience but concerned that a low P/S and high yield could still mask value traps in the sector? Take a look at our hand picked list of solid balance sheet and fundamentals stocks (414 results) for companies that pair earnings power with stronger fundamentals.
Q2 2026 Earnings Summary
- Revenue (Q2 2026 vs Q2 2025): €2,427.8m vs €2,395.6m (up 1.3%)
- Net Income (Excl. Extra Items, Q2 2026 vs Q2 2025): €25.0m vs €23.5m (up 6.4%)
- Basic EPS (Q2 2026 vs Q2 2025): €0.33 vs €0.31 (up 6.6%)
- EBITDA Margin (Q2 2026 vs Q2 2025): 16.1%, with about 90 bps of margin recovery (improving trend)
Prefer clean visuals instead of scrolling through dense financial tables? See Arkema's full financial picture, including its valuation setup in our company report for Arkema.
Arkema Margins Start To Do The Heavy Lifting
Bulls argue that Arkema’s pivot into higher value specialties should show up first in more resilient margins, not just headline growth. Q2 lines up with that claim. EBITDA of €391m with a 16.1% margin and about 90 bps of margin recovery came in a quarter where volumes fell 1.8% and demand in Europe and the U.S. stayed weak. That points directly to mix, pricing and cost control doing the work that the specialty narrative promises.
The earnings bridge also matters. Specialty Materials strength, including a record Q2 for Adhesive Solutions and solid Advanced Materials, offset pressure in Performance Additives and Primary Materials. Management quantified about €25m of extra EBITDA from major projects in the first half and still targets about €50m for 2026, which is a concrete milestone for the capacity led bull story. With guidance for slight full year EBITDA growth reaffirmed, Arkema is at least tracking the operational roadmap that optimists wanted to see.
Reveal where the surface looks calm, but the models start to disagree on Arkema's next inflection point, and see what the street is quietly building into the outer year revenue and EBITDA path with the analyst estimates for Arkema.Arkema Bears Still See Slow Transition Risks
The bearish worry is that Arkema remains too exposed to legacy, cyclical chemicals and that the shift to higher value materials is too slow to offset structural pressures. Q2 does not fully clear that concern. Specialty Materials and Coating Solutions carried the quarter, yet Performance Additives and Primary Materials again showed how exposed earnings remain to sulfur spikes, acrylic spreads and weak refining and fertilizer demand. Volumes fell 1.8% despite mix and pricing doing the heavy lifting, which keeps the risk of demand driven margin pressure alive if pricing power fades.
Bears also flag execution and complexity risk in a broad portfolio. The group is adding roughly €50m of project EBITDA this year, but net debt of about €3.6b and leverage around 2.9x LTM EBITDA leave less room for error if growth projects or decarbonization costs disappoint. The earnings recovery is real, yet the portfolio and balance sheet mix still leave several bearish milestones only partially addressed.
After thin net margins, large one off items and a heavily stretched dividend, you may want to review our risk analysis for Arkema which shows 3 important warning signs.Stay Ahead With Arkema Insights
If Arkema's margin recovery and low P/S have caught your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch for a setup that fits your plan. Once you have taken a position, keep a clear view of how Arkema and your other holdings fit together using the Portfolio Command Center that filters out noise and highlights what really matters. For a broader perspective on what other investors are seeing in Arkema, tap into the Community and compare different views and thesis updates. By surfacing potential catalysts and risks early, Simply Wall St helps you act with confidence and stay a step ahead of the market.
Seeking Alternatives Beyond Arkema Today
Fresh stock ideas can move from quiet to flying quickly. Use curated screeners to spot potential breakouts before the crowd catches on while it matters. Get in early.
- Hunt for steady income opportunities and shortlist potential high yield candidates with the curated 432 dividend fortresses before yields drop as more investors catch on.
- Track where real cash flow meets AI momentum and scan the hand picked 69 profitable AI stocks that aren't just burning cash before these stories move out of under the radar territory.
- Position for the long build out of next generation power systems and review the focused 35 power grid technology and infrastructure stocks while these infrastructure plays remain quietly priced.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com